Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
The strategic end state for Lateral Flow Device (LFD) COVID-19 testing is one where citizens can test themselves using LFDs and report results without professional assistance with either the swabbing or the test analysis. This Letter of Intent is for proof of concept work to demonstrate computer vision technology that will automatically analyse test results from photos captured by the users.
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| Sensyne Health Group Limited | 11240986 | £247,000 | - |
Government spending data: This supplier has received £1,459,336 in 20 payments (over £25k) from Department of Health and Social Care, UK Health Security Agency (2021-01-25 to 2022-05-27). View full payment history →